Morgan Stanley Upgrades Amicus Therapeutics (FOLD) to Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

December 19, 2023 3:12 AM EST
Get Alerts FOLD Hot Sheet
Price: $14.49 --0%

Rating Summary:
    12 Buy, 9 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Morgan Stanley analyst Jeffrey Hung upgraded Amicus Therapeutics (NASDAQ: FOLD) from Equalweight to Overweight with a price target of $20.00 (from $15.00).


For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.


Shares of Amicus Therapeutics closed at $12.66 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades